4 results
6-K
EX-10.3
PHXM
PHAXIAM Therapeutics S.A.
16 Dec 21
Erytech Announces Presentation of Results of Expanded Access Program In All at 2021 Ash Annual Meeting and Acceptance of Two Abstracts at Asco Gi
5:23pm
is true, complete and correct in all material respects.
(38) [Reserved.]
(39) Statistical and Market-Related Data. All statistical, demographic
6-K
EX-10.3
PHXM
PHAXIAM Therapeutics S.A.
3 May 21
ERYTECH Announces $30.0 Million
5:20pm
-Related Data. All statistical, demographic and market-related data included in or incorporated by reference in the Registration Statement or the Prospectus
F-3
EX-1.2
PHXM
PHAXIAM Therapeutics S.A.
21 Sep 20
Shelf registration (foreign)
5:26pm
-Related Data. All statistical, demographic and market-related data included in or incorporated by reference in the Registration Statement or the Prospectus
- Prev
- 1
- Next